KUAISHOU-W (01024) granted a total of 9.79433 million restricted share units.
-W (01024) announced that on January 20, 2025, the company will issue a certain number of shares to eligible participants in accordance with the...
KUAISHOU-W (01024) announced that on January 20, 2025, the company granted a total of 9.79433 million restricted stock units to eligible participants under the 2023 share incentive plan, but they must be accepted by the grantees before they can become effective.
Related Articles
E&P GLOBAL (01142) received a summons filed by Daily Loyal Limited to the Hong Kong High Court.
INNOCARE (09969): The phase IIb clinical trial of olokizumab in the treatment of systemic lupus erythematosus has achieved positive results and the phase III clinical trial has been initiated.
DUALITYBIO-B(09606) recommends adopting the 2025 stock plan.
E&P GLOBAL (01142) received a summons filed by Daily Loyal Limited to the Hong Kong High Court.
INNOCARE (09969): The phase IIb clinical trial of olokizumab in the treatment of systemic lupus erythematosus has achieved positive results and the phase III clinical trial has been initiated.
DUALITYBIO-B(09606) recommends adopting the 2025 stock plan.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
